75 related articles for article (PubMed ID: 24942130)
41. Identification and molecular characterization of a novel PDE4D11 cAMP-specific phosphodiesterase isoform.
Lynex CN; Li Z; Chen ML; Toh KY; Low RW; Goh DL; Tay SK
Cell Signal; 2008 Dec; 20(12):2247-55. PubMed ID: 18804162
[TBL] [Abstract][Full Text] [Related]
42. Design and synthesis of 4-alkynyl pyrazoles as inhibitors of PDE4: a practical access via Pd/C-Cu catalysis.
Gorja DR; Shiva Kumar K; Kandale A; Meda CL; Parsa KV; Mukkanti K; Pal M
Bioorg Med Chem Lett; 2012 Apr; 22(7):2480-7. PubMed ID: 22381049
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and biological activity of pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives as novel and potent phosphodiesterase type 4 inhibitors.
Taltavull J; Serrat J; Gràcia J; Gavaldà A; Córdoba M; Calama E; Montero JL; Andrés M; Miralpeix M; Vilella D; Hernández B; Beleta J; Ryder H; Pagès L
Eur J Med Chem; 2011 Oct; 46(10):4946-56. PubMed ID: 21871695
[TBL] [Abstract][Full Text] [Related]
44. PDE4D plays a critical role in the control of airway smooth muscle contraction.
Méhats C; Jin SL; Wahlstrom J; Law E; Umetsu DT; Conti M
FASEB J; 2003 Oct; 17(13):1831-41. PubMed ID: 14519662
[TBL] [Abstract][Full Text] [Related]
45. Phosphodiesterase-4 inhibition augments human lung fibroblast vascular endothelial growth factor production induced by prostaglandin E2.
Ikari J; Michalski JM; Iwasawa S; Gunji Y; Nogel S; Park JH; Nelson AJ; Farid M; Wang X; Schulte N; Basma H; Toews ML; Feghali-Bostwick C; Tenor H; Liu X; Rennard SI
Am J Respir Cell Mol Biol; 2013 Oct; 49(4):571-81. PubMed ID: 23656623
[TBL] [Abstract][Full Text] [Related]
46. Effects of phosphodiesterase inhibitors on tension induced by norepinephrine and accumulation of cyclic nucleotides in isolated human prostatic tissue.
Uckert S; Sormes M; Kedia G; Scheller F; Knapp WH; Jonas U; Stief CG
Urology; 2008 Mar; 71(3):526-30. PubMed ID: 18342202
[TBL] [Abstract][Full Text] [Related]
47. The phosphodiesterase type 4 inhibitor, rolipram, enhances glucocorticoid receptor function.
Miller AH; Vogt GJ; Pearce BD
Neuropsychopharmacology; 2002 Dec; 27(6):939-48. PubMed ID: 12464451
[TBL] [Abstract][Full Text] [Related]
48. Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats.
Itoh T; Tokumura M; Abe K
Eur J Pharmacol; 2004 Sep; 498(1-3):135-42. PubMed ID: 15363987
[TBL] [Abstract][Full Text] [Related]
49. Evidence for global reduction in brain cyclic adenosine monophosphate signaling in depression.
O'Donnell JM; Xu Y
Biol Psychiatry; 2012 Oct; 72(7):524-5. PubMed ID: 22959119
[No Abstract] [Full Text] [Related]
50. Discriminative stimulus effects of the type-4 phosphodiesterase inhibitor rolipram in rats.
Makhay MM; Houslay MD; O'Donnell JM
Psychopharmacology (Berl); 2001 Nov; 158(3):297-304. PubMed ID: 11713620
[TBL] [Abstract][Full Text] [Related]
51. Phosphodiesterase inhibitors. Part 2: design, synthesis, and structure-activity relationships of dual PDE3/4-inhibitory pyrazolo[1,5-a]pyridines with anti-inflammatory and bronchodilatory activity.
Ochiai K; Ando N; Iwase K; Kishi T; Fukuchi K; Ohinata A; Zushi H; Yasue T; Adams DR; Kohno Y
Bioorg Med Chem Lett; 2011 Sep; 21(18):5451-6. PubMed ID: 21764304
[TBL] [Abstract][Full Text] [Related]
52. Improving the relaxing effect of terbutaline with phosphodiesterase inhibitors: studies on pregnant rat uteri in vitro.
Klukovits A; Verli J; Falkay G; Gáspár R
Life Sci; 2010 Dec; 87(23-26):733-7. PubMed ID: 20970435
[TBL] [Abstract][Full Text] [Related]
53. Compound D159687, a phosphodiesterase 4D inhibitor, induces weight and fat mass loss in aged mice without changing lean mass, physical and cognitive function.
Muo IM; Park SJ; Smith A; A Springer D; Allen MD; Hagen TJ; Chung JH
Biochem Biophys Res Commun; 2018 Dec; 506(4):1059-1064. PubMed ID: 30409425
[TBL] [Abstract][Full Text] [Related]
54. Memory-enhancing drugs: a molecular perspective.
Monti B; Contestabile A
Mini Rev Med Chem; 2009 Jun; 9(7):769-81. PubMed ID: 19519502
[TBL] [Abstract][Full Text] [Related]
55. Colostrinin and colostrinin-derived nonapeptide (colostral-val nonapeptide, CVNP) facilitate learning and memory in rats.
Popik P
Pol J Pharmacol; 2001; 53(2):166-8. PubMed ID: 11787957
[No Abstract] [Full Text] [Related]
56. Cell biology. Blocking stress response for better memory?
Hinnebusch AG
Science; 2015 May; 348(6238):967-8. PubMed ID: 26023119
[No Abstract] [Full Text] [Related]
57. Phosphodiesterase 4D Gene Modifies the Functional Network of Patients With Mild Cognitive Impairment and Alzheimer's Disease.
Xiang J; Wang X; Gao Y; Li T; Cao R; Yan T; Ma Y; Niu Y; Xue J; Wang B
Front Genet; 2020; 11():890. PubMed ID: 32849849
[TBL] [Abstract][Full Text] [Related]
58. Phosphodiesterase 4D: an enzyme to remember.
Ricciarelli R; Fedele E
Br J Pharmacol; 2015 Oct; 172(20):4785-9. PubMed ID: 26211680
[TBL] [Abstract][Full Text] [Related]
59. PDE4D inhibitors: a potential strategy for the treatment of memory impairment?
Bruno O; Ricciarelli R; Prickaerts J; Parker L; Fedele E
Neuropharmacology; 2014 Oct; 85():290-2. PubMed ID: 24942130
[No Abstract] [Full Text] [Related]
60. New insights into selective PDE4D inhibitors: 3-(Cyclopentyloxy)-4-methoxybenzaldehyde O-(2-(2,6-dimethylmorpholino)-2-oxoethyl) oxime (GEBR-7b) structural development and promising activities to restore memory impairment.
Brullo C; Ricciarelli R; Prickaerts J; Arancio O; Massa M; Rotolo C; Romussi A; Rebosio C; Marengo B; Pronzato MA; van Hagen BTJ; van Goethem NP; D'Ursi P; Orro A; Milanesi L; Guariento S; Cichero E; Fossa P; Fedele E; Bruno O
Eur J Med Chem; 2016 Nov; 124():82-102. PubMed ID: 27560284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
